Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
alexion pharmaceuticals
alirocumab
amgen
amyotrophic lateral sclerosis (als)
autoimmune disorders
biobucks
boston
boulder/denver blog main
boulder/denver top stories
calistoga pharmaceuticals
car-t immunotherapy
cardiac
cardiovascular
cause of death
cedar-sinai
checkpoint inhibitors
cholesterol
circulation
clinical studies
clinical trials
complement system
david maron
deals
detroit blog main
detroit top stories
esperion pharmaceuticals
evolocumab
fda
fh foundation
generalized myasthenia gravis
What
drug
expensive
3
×
adding
alternative
autoimmune
bets
boost
cancer
candidate
cholesterol
deal
disease
drugs
faces
far
financial
foe
gilead
healthcare
hint
inhibitors
known
lead
lowering
medicines
million
new
paying
pcsk
pharma
pharmaceuticals
pipeline
potential
program
ra
remember
sciences
stakes
startup
startup's
Language
unset
Current search:
expensive
×
biotech
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
